Compare STXS & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STXS | BDSX |
|---|---|---|
| Founded | 1990 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.1M | 153.3M |
| IPO Year | 2004 | 2020 |
| Metric | STXS | BDSX |
|---|---|---|
| Price | $1.30 | $21.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $4.00 | ★ $32.50 |
| AVG Volume (30 Days) | ★ 1.2M | 53.8K |
| Earning Date | 05-12-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $29,346,617.00 | ★ $88,499,000.00 |
| Revenue This Year | $28.22 | $25.26 |
| Revenue Next Year | $30.47 | $19.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 24.08 |
| 52 Week Low | $1.24 | $0.35 |
| 52 Week High | $3.59 | $24.92 |
| Indicator | STXS | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 32.44 | 57.01 |
| Support Level | N/A | $19.00 |
| Resistance Level | $1.97 | $24.47 |
| Average True Range (ATR) | 0.12 | 1.60 |
| MACD | -0.01 | -0.16 |
| Stochastic Oscillator | 10.16 | 57.20 |
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.